Read More Pharma Industry News Avacta Group reports promising early results for Phase 1a study of AVA6000 Avacta Group plc (AIM: AVCT), a leading life sciences company dedicated to developing innovative oncology drugs and powerful… byPallavi MadhirajuMarch 23, 2024